ATE387208T1 - Antivirale mittel aus pflanzenextrakten und deren verwendung zur behandlung viraler infektionen - Google Patents

Antivirale mittel aus pflanzenextrakten und deren verwendung zur behandlung viraler infektionen

Info

Publication number
ATE387208T1
ATE387208T1 AT97933463T AT97933463T ATE387208T1 AT E387208 T1 ATE387208 T1 AT E387208T1 AT 97933463 T AT97933463 T AT 97933463T AT 97933463 T AT97933463 T AT 97933463T AT E387208 T1 ATE387208 T1 AT E387208T1
Authority
AT
Austria
Prior art keywords
virus
compositions
hepatitis
hiv
treatment
Prior art date
Application number
AT97933463T
Other languages
English (en)
Inventor
Hsiu-Hsien Tsai
Shie-Ming Hwang
Original Assignee
Hsiu-Hsien Tsai
Shie-Ming Hwang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hsiu-Hsien Tsai, Shie-Ming Hwang filed Critical Hsiu-Hsien Tsai
Application granted granted Critical
Publication of ATE387208T1 publication Critical patent/ATE387208T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/638—Ligustrum, e.g. Chinese privet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97933463T 1996-07-09 1997-07-09 Antivirale mittel aus pflanzenextrakten und deren verwendung zur behandlung viraler infektionen ATE387208T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1610096P 1996-07-09 1996-07-09
US2146796P 1996-07-10 1996-07-10

Publications (1)

Publication Number Publication Date
ATE387208T1 true ATE387208T1 (de) 2008-03-15

Family

ID=26688168

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97933463T ATE387208T1 (de) 1996-07-09 1997-07-09 Antivirale mittel aus pflanzenextrakten und deren verwendung zur behandlung viraler infektionen

Country Status (12)

Country Link
US (3) US5837257A (de)
EP (1) EP0914139B1 (de)
JP (1) JP2001516337A (de)
KR (1) KR100511514B1 (de)
AT (1) ATE387208T1 (de)
AU (1) AU742854B2 (de)
BR (1) BR9710355A (de)
CA (1) CA2271622C (de)
DE (1) DE69738535T2 (de)
ES (1) ES2303342T3 (de)
NZ (1) NZ333707A (de)
WO (1) WO1998001144A1 (de)

Families Citing this family (140)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100346609B1 (ko) * 1994-12-28 2002-11-18 주식회사 엘지씨아이 금은화로부터세코노가노사이드를추출하는방법
US5837257A (en) * 1996-07-09 1998-11-17 Sage R&D Use of plant extracts for treatment of HIV, HCV and HBV infections
KR100239879B1 (ko) * 1997-11-05 2000-02-01 김상조 간암 예방 및 치료용 생약제
US6524625B2 (en) * 1998-06-30 2003-02-25 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyuto Physiologically active extract obtained from indigo plant polygonum tinctorium
US6358060B2 (en) 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
WO2000061159A1 (de) * 1999-04-14 2000-10-19 Max Zeller Söhne Ag ARZNEIMITTEL ZUR HEMMUNG VON NF-λB
JP2003504347A (ja) * 1999-07-13 2003-02-04 フン アーン、デウク 生薬剤を用いた女性用生理ナプキン塗布用組成物
EP1207907B1 (de) 1999-08-13 2004-11-03 University Of Maryland Biotechnology Institute Zusammensetzungen zur behandlung von viralen infektionen und verfahren dafür
US6103242A (en) * 1999-10-21 2000-08-15 Buckley; William Method of controlling blood sugar levels using Coccoloba uvifera
CN1173965C (zh) * 2000-03-30 2004-11-03 科学与工业研究会 从植物黄花蒿中分离化合物东莨菪亭的方法
AU2001261744A1 (en) * 2000-05-19 2001-12-03 Npd Llc Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
US7045159B1 (en) 2000-09-19 2006-05-16 Rutgers, The State University Of New Jersey Antiviral substances from plant cuticular and epiciticular material
US6455078B1 (en) 2000-10-18 2002-09-24 Tzu-Sheng Wu Medicinal herbal composition for treating liver diseases and HIV
US6696094B2 (en) * 2000-10-18 2004-02-24 Tzu-Sheng Wu Herbal pharmaceutical composition for treatment of HIV/AIDS patients
CN1309399C (zh) 2000-10-25 2007-04-11 国家中药制药工程技术研究中心 复方双黄连制剂及制备方法
AU2002227252A1 (en) * 2000-12-01 2002-06-11 Cornell Research Foundation Animal model for flaviviridae infection
JP4880816B2 (ja) * 2000-12-15 2012-02-22 株式会社ヤクルト本社 皮膚老化防止剤
US6455070B1 (en) 2001-02-15 2002-09-24 East Park Research, Inc. Composition for treating symptoms of influenza
CN1220498C (zh) * 2001-04-02 2005-09-28 李洪芬 一种治疗哮喘的药剂
US20030054047A1 (en) * 2001-06-15 2003-03-20 Sanjiu Medical & Pharmaceutical Co., Ltd. Pharmaceutical composition for the treatment of viral infection
US20030054978A1 (en) * 2001-08-31 2003-03-20 Babish John G. Arginine compositions for coordinate modification of multiple cardiovascular risk factors
AU2002330154A1 (en) * 2001-09-28 2003-04-07 Centre National De La Recherche Scientifique Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
WO2003030635A1 (en) * 2001-10-11 2003-04-17 Natural Remedies Private Limited A herbal hepatoprotective and weight gain promoter and a process thereof
US6541045B1 (en) * 2002-01-04 2003-04-01 Nutraceutical Corporation Herbal composition and method for combating inflammation
AU2003247084B9 (en) 2002-06-28 2018-07-26 Centre National De La Recherche Scientifique Modified 2' and 3'-nucleoside prodrugs for treating flaviridae infections
AU2003244587B2 (en) * 2002-07-12 2009-06-25 Academia Sinica Use of Anoectochilus Formosanus plant extracts and their derived fractions as herbal medicines or nutraceutical supplements for chemoprevention or treatment of human malignancies
US7033617B2 (en) * 2002-07-12 2006-04-25 Academia Sinica Use of Anoectochilus formosanus plant extracts and their derived fractions as herbal medicines or nutraceutical supplements for chemoprevention or treatment of human malignancies
EP1545545A4 (de) * 2002-08-01 2008-09-03 Pharmasset Inc VERBINDUNGEN MIT DEM BICYCLO 4.2.1 NONAN-SYSTEM ZUR BEHANDLUNG VON i FLAVIVIRIDAE /i INFEKTIONEN
US20040151787A1 (en) * 2002-11-21 2004-08-05 Pero Ronald W. Water soluble compositions derived from plant material and preparation thereof
US20040126351A1 (en) * 2002-12-26 2004-07-01 Avon Products, Inc. Topical composition having natural skin anti-irritant ingredient and method of use
WO2004064759A2 (en) * 2003-01-21 2004-08-05 Chiron Corporation Use of tryptanthrin compounds for immune potentiation
TWI269656B (en) * 2003-03-05 2007-01-01 Original Image Co Ltd Therapeutical composition for hepatitis C
KR101000953B1 (ko) * 2003-05-16 2010-12-13 안경민 비수리 추출물 및 그 용도
US20040234546A1 (en) * 2003-05-19 2004-11-25 Amazon Biotech Inc. Treatments using an herbal composition
US7160561B2 (en) 2003-05-19 2007-01-09 Amazon Biotech Inc. Herbal composition and method of treating HIV infection
RU2358979C2 (ru) 2003-05-30 2009-06-20 Фармассет, Инк. Модифицированные фторированные аналоги нуклеозида
TWI315200B (en) * 2003-06-13 2009-10-01 Ind Tech Res Inst An herbal extract having anti-enterovirus activity and preparation of same
US7648717B2 (en) * 2003-06-13 2010-01-19 Industrial Technology Research Institute Herbal extract having anti-virus activity and preparation of same
ATE478886T1 (de) 2003-07-25 2010-09-15 Idenix Pharmaceuticals Inc Purin nucleoside für die behandlung von durch flavividrae verursachten krankheiten, einschliesslich hepatitis c
FR2859107B1 (fr) * 2003-08-26 2008-04-18 Oyoubi Pierre Pyebi Utilisation des extraits d'une graminee, d'une rutacee et d'une pieridophyte dans une composition pharmaceutique a activite antivirale, antibacterienne, antifongique et aussi destinee a stimuler les defenses immunitaires
GB0500020D0 (en) 2005-01-04 2005-02-09 Novartis Ag Organic compounds
CN1330359C (zh) * 2004-04-09 2007-08-08 北京琦杰源医药科技发展有限公司 一种治疗艾滋病的中药制剂及其加工方法
SE0400996D0 (sv) * 2004-04-16 2004-04-16 Alltech Ireland Inc Use of plants, plant extracts and nature-identical components from plants to affect the rumen fermentation and to improve the energy and protein retention of ruminants
CN101023094B (zh) 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
US8008280B2 (en) * 2004-09-10 2011-08-30 Biorings Llc Betulinol derivatives as anti-HIV agents
ES2725457T3 (es) 2004-09-14 2019-09-24 Gilead Pharmasset Llc Preparación de ribofuranosil pirimidinas y purinas 2'fluoro-2'-alquil-sustituidas u otras opcionalmente sustituidas y sus derivados
US20060110479A1 (en) * 2004-11-24 2006-05-25 Mitra Shankar K Natural composition for curing hepatitis-B, methods for making the same and pharmaceutical formulations thereof
US7615240B2 (en) * 2005-01-07 2009-11-10 Auburn University Method and composition for the control of gastrointestinal parasites in animals
KR100661032B1 (ko) * 2005-04-19 2006-12-22 주식회사한국야쿠르트 간 기능 개선, 혈중 알코올 감소 및 항산화에 유효한조성물
US7556830B2 (en) * 2005-08-22 2009-07-07 International Patents Holdings, Ltd. Medicinal herbal composition for treating infection
DE202005015707U1 (de) * 2005-10-06 2006-04-20 Sheng Foong Pharmaceutical Co. Ltd., Su-Ao Chen Kräuterzusammensetzung zur Behandlung von Krebs
TWI370739B (en) * 2005-12-30 2012-08-21 Ind Tech Res Inst Herbal compositions of inhibiting free radicals
US8980336B2 (en) * 2005-12-30 2015-03-17 Industrial Technology Research Institute Method for inhibiting free radicals
EP2518079A3 (de) 2006-04-11 2012-12-12 Novartis AG HCV/HIV-Hemmer und Benutzung davon
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
US20080057111A1 (en) * 2006-08-29 2008-03-06 Lixian Jiang Herbal composition for flu prevention and treatment
US9005889B2 (en) * 2007-01-16 2015-04-14 The Johns Hopkins University Synergistic antiviral compositions comprising a viral attachment inhibitor, integration inhibitor, and proviral transcription inhibitor
WO2008106166A2 (en) 2007-02-28 2008-09-04 Conatus Pharmaceuticals, Inc. Methods for the treatment of liver diseases using specified matrix metalloproteinase (mmp) inhibitors
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
US20090053335A1 (en) * 2007-04-13 2009-02-26 Chih-Hui Lin Herbal compositions for the inhibition of human immunodeficiency virus (hiv)
US20080254148A1 (en) * 2007-04-13 2008-10-16 Gerent Biotech Co. Herbal compositions for the inhibition of human immunodeficiency virus
US8067401B2 (en) * 2007-09-06 2011-11-29 International Patent Holdings Llc Compounds and compositions for treating infection
AU2008296136A1 (en) * 2007-09-07 2009-03-12 Bionovo. Inc. Estrogenic extracts of Scuttelaria barbata D. Don of the Labiatae Family and uses thereof
TW200946541A (en) * 2008-03-27 2009-11-16 Idenix Pharmaceuticals Inc Solid forms of an anti-HIV phosphoindole compound
TWI366466B (en) * 2008-05-08 2012-06-21 Ind Tech Res Inst Herbal extracts capable of inducing immune cells to produce interferon and activating toll-like receptors and the preparation thereof
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
KR20110065440A (ko) 2008-07-02 2011-06-15 아이데닉스 파마슈티칼스, 인코포레이티드 바이러스 감염의 치료를 위한 화합물 및 제약 조성물
US8197861B2 (en) 2008-10-02 2012-06-12 George Zabrecky Methods and formulations for treating chronic liver disease
CL2009002206A1 (es) 2008-12-23 2011-08-26 Gilead Pharmasset Llc Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
AR074897A1 (es) 2008-12-23 2011-02-23 Pharmasset Inc Fosforamidatos de nucleosidos
MX2011006890A (es) 2008-12-23 2011-07-20 Pharmasset Inc Analogos de nucleosidos.
WO2010101967A2 (en) 2009-03-04 2010-09-10 Idenix Pharmaceuticals, Inc. Phosphothiophene and phosphothiazole hcv polymerase inhibitors
US20110182850A1 (en) 2009-04-10 2011-07-28 Trixi Brandl Organic compounds and their uses
US8512690B2 (en) 2009-04-10 2013-08-20 Novartis Ag Derivatised proline containing peptide compounds as protease inhibitors
TWI576352B (zh) 2009-05-20 2017-04-01 基利法瑪席特有限責任公司 核苷磷醯胺
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
AR077712A1 (es) 2009-08-05 2011-09-14 Idenix Pharmaceuticals Inc Inhibidores de serina proteasa macrociclica
WO2011063076A1 (en) 2009-11-19 2011-05-26 Itherx Pharmaceuticals, Inc. Methods of treating hepatitis c virus with oxoacetamide compounds
JP5651834B2 (ja) * 2009-12-14 2015-01-14 豊勝 堀川 赤血球凝集阻害剤、および赤血球の凝集阻害方法
MY159958A (en) 2009-12-18 2017-02-15 Idenix Pharmaceuticals Inc 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
AU2010337947B2 (en) * 2009-12-30 2015-11-05 Bagi Research Limited Materials and methods for prevention and treatment of viral infections
AP2012006535A0 (en) 2010-03-31 2012-10-31 Gilead Pharmasset Llc Stereoselective synthesis of phosphorous containing actives
PL3290428T3 (pl) 2010-03-31 2022-02-07 Gilead Pharmasset Llc Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
TWI515000B (zh) 2010-04-01 2016-01-01 伊迪尼克製藥公司 用於治療病毒感染之化合物及醫藥組合物
CN103179966B (zh) 2010-10-08 2017-03-15 诺瓦提斯公司 磺酰胺ns3抑制剂的维生素e制剂
ES2716158T3 (es) 2010-11-30 2019-06-10 Gilead Pharmasset Llc 2'-spiro-nucleótidos para el tratamiento de hepatitis C
WO2012080050A1 (en) 2010-12-14 2012-06-21 F. Hoffmann-La Roche Ag Solid forms of a phenoxybenzenesulfonyl compound
KR20120080674A (ko) * 2011-01-08 2012-07-18 주식회사한국전통의학연구소 대계근 추출물을 포함하는 백혈병 치료용 조성물 및 건강 기능성 식품
US8618125B2 (en) 2011-01-14 2013-12-31 Heptiva LLC Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance
TW201309690A (zh) 2011-02-10 2013-03-01 Idenix Pharmaceuticals Inc 巨環絲胺酸蛋白酶抑制劑,其醫藥組合物及其於治療hcv感染之用途
US9243025B2 (en) 2011-03-31 2016-01-26 Idenix Pharmaceuticals, Llc Compounds and pharmaceutical compositions for the treatment of viral infections
US20120252721A1 (en) 2011-03-31 2012-10-04 Idenix Pharmaceuticals, Inc. Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
WO2012143017A1 (en) 2011-04-17 2012-10-26 El-Sawy Mohamed Fakhr El-Din The use of orobancheace extract for the treatment of hepatitis c virus and nonalcoholic fatty liver disease
US9403863B2 (en) 2011-09-12 2016-08-02 Idenix Pharmaceuticals Llc Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections
AU2012308900A1 (en) 2011-09-12 2013-05-09 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of viral infections
AR089650A1 (es) 2011-10-14 2014-09-10 Idenix Pharmaceuticals Inc Fosfatos 3,5-ciclicos sustituidos de compuestos de nucleotido de purina y composiciones farmaceuticas para el tratamiento de infecciones virales
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
US9089574B2 (en) 2011-11-30 2015-07-28 Emory University Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
CN103127205B (zh) * 2011-12-02 2018-07-31 天津市国际生物医药联合研究院有限公司 中药夜关门及其提取物的制药用途
US8809354B2 (en) 2011-12-31 2014-08-19 Sheikh Riazuddin 3-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone or derivatives thereof for treating or preventing antiviral infections
WO2013133927A1 (en) 2012-02-13 2013-09-12 Idenix Pharmaceuticals, Inc. Pharmaceutical compositions of 2'-c-methyl-guanosine, 5'-[2-[(3-hydroxy-2,2-dimethyl-1-oxopropyl)thio]ethyl n-(phenylmethyl)phosphoramidate]
TWI498118B (zh) * 2012-04-27 2015-09-01 財團法人工業技術研究院 促進傷口癒合及血管新生的醫藥組合物與接骨木屬(蒴藋屬)(Sambucus)植物及菘藍屬(Isatis)植物之萃取物用於製備促進傷口癒合及血管新生之藥物的用途
MD20140134A2 (ro) 2012-05-22 2015-04-30 Idenix Pharmaceuticals, Inc. Compuşi ai D-aminoacizilor pentru tratamentul bolilor hepatice
EP2852604B1 (de) 2012-05-22 2017-04-12 Idenix Pharmaceuticals LLC 3',5'-cyclische phosphoramidat-prodrugs für hcv-infektion
WO2013177195A1 (en) 2012-05-22 2013-11-28 Idenix Pharmaceuticals, Inc. 3',5'-cyclic phosphate prodrugs for hcv infection
ES2674980T3 (es) 2012-10-08 2018-07-05 Idenix Pharmaceuticals Llc Análogos de 2'-cloro nucleósidos para infección por VHC
EP2909223B1 (de) 2012-10-19 2017-03-22 Idenix Pharmaceuticals LLC Dinukleotidverbindungen für hcv-infektion
WO2014066239A1 (en) 2012-10-22 2014-05-01 Idenix Pharmaceuticals, Inc. 2',4'-bridged nucleosides for hcv infection
WO2014078427A1 (en) 2012-11-14 2014-05-22 Idenix Pharmaceuticals, Inc. D-alanine ester of rp-nucleoside analog
WO2014078436A1 (en) 2012-11-14 2014-05-22 Idenix Pharmaceuticals, Inc. D-alanine ester of sp-nucleoside analog
US9211300B2 (en) 2012-12-19 2015-12-15 Idenix Pharmaceuticals Llc 4′-fluoro nucleosides for the treatment of HCV
WO2014137926A1 (en) 2013-03-04 2014-09-12 Idenix Pharmaceuticals, Inc. 3'-deoxy nucleosides for the treatment of hcv
WO2014137930A1 (en) 2013-03-04 2014-09-12 Idenix Pharmaceuticals, Inc. Thiophosphate nucleosides for the treatment of hcv
EP2981542B1 (de) 2013-04-01 2021-09-15 Idenix Pharmaceuticals LLC 2',4'-fluor-nukleoside zur behandlung von hcv
EP3004130B1 (de) 2013-06-05 2019-08-07 Idenix Pharmaceuticals LLC. 1',4'-thionukleoside zur behandlung von hcv
US20150037282A1 (en) 2013-08-01 2015-02-05 Idenix Pharmaceuticals, Inc. D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
EA201690473A1 (ru) 2013-08-27 2017-03-31 ГАЙЛИД ФАРМАССЕТ ЭлЭлСи Комбинированный состав двух противовирусных соединений
EP3046924A1 (de) 2013-09-20 2016-07-27 IDENIX Pharmaceuticals, Inc. Inhibitoren des hepatitis-c-virus
WO2015061683A1 (en) 2013-10-25 2015-04-30 Idenix Pharmaceuticals, Inc. D-amino acid phosphoramidate and d-alanine thiophosphoramidate pronucleotides of nucleoside compounds useful for the treatment of hcv
WO2015066370A1 (en) 2013-11-01 2015-05-07 Idenix Pharmaceuticals, Inc. D-alanine phosphoramidate pronucleotides of 2'-methyl 2'-fluoro guanosine nucleoside compounds for the treatment of hcv
EP3074399A1 (de) 2013-11-27 2016-10-05 Idenix Pharmaceuticals LLC 2'-dichlor- und 2'-fluor-2'-chlor-nukleosidanaloga für hcv-infektion
US10130728B2 (en) 2013-12-16 2018-11-20 3M Innovative Properties Company Systems and methods for controlling humidity
WO2015095419A1 (en) 2013-12-18 2015-06-25 Idenix Pharmaceuticals, Inc. 4'-or nucleosides for the treatment of hcv
WO2015134560A1 (en) 2014-03-05 2015-09-11 Idenix Pharmaceuticals, Inc. Solid forms of a flaviviridae virus inhibitor compound and salts thereof
US20170135990A1 (en) 2014-03-05 2017-05-18 Idenix Pharmaceuticals Llc Pharmaceutical compositions comprising a 5,5-fused heteroarylene flaviviridae inhibitor and their use for treating or preventing flaviviridae infection
EP3131914B1 (de) 2014-04-16 2023-05-10 Idenix Pharmaceuticals LLC 3'-substituierte methyl- oder alkynylnukleoside zur behandlung von hcv
US9789153B2 (en) 2014-07-02 2017-10-17 Hsiu-Hsien Tsai Composition for preventing cancer and treating cancer and intensifying the effects of other anticancer drugs
CN109010349B (zh) * 2018-10-29 2020-11-06 湖北中医药大学 白芨寡糖在改善肠道微生态中的应用
CN109917034A (zh) * 2019-03-19 2019-06-21 遵义医科大学 一种白及悬浮培养细胞中2,7-二羟基-4-甲氧基-9,10-二氢菲的定量检测方法
CN110179951A (zh) * 2019-06-28 2019-08-30 宗吉红 一种调治病毒性肝炎的中药组合物及其制备方法
KR102321162B1 (ko) * 2019-11-25 2021-11-02 강원대학교 산학협력단 황백 추출물을 유효성분으로 포함하는 산화아연 저감 사료용 보조제 조성물
CN115867301B (zh) * 2020-12-14 2025-12-12 协力志业股份有限公司 草药组合物、其制备方法及将其施用以用于预防或治疗病毒感染的方法
US20240226220A9 (en) * 2021-02-12 2024-07-11 Arizona Board Of Regents On Behalf Of Arizona State University Oral botanical composition
KR102607247B1 (ko) * 2021-03-25 2023-11-29 한국식품연구원 도깨비고비 추출물을 유효성분으로 포함하는 항암 조성물
US20210361733A1 (en) * 2021-08-06 2021-11-25 Atta-ur- Rahman Prevention and Treatment of SARS-CoV-2 Infection by Mentha piperita and Flos chrysanthemi Extracts alone, and their Combination
KR102389589B1 (ko) * 2021-09-29 2022-04-22 진지영 야관문 추출물을 포함하는 사료용 항진균성 조성물 및 그의 제조 방법
PL245314B1 (pl) * 2022-07-15 2024-06-24 Inst Chemii Fizycznej Polskiej Akademii Nauk Zastosowanie soli sodowej kwasu 5,5’-indygodisulfonowego do hamowania infekcji bakteriofagowych w procesach biotechnologicznych
US20240148816A1 (en) * 2022-11-07 2024-05-09 King Saud University Herbal composition comprising solanum nigrum for the treatment of cancer
CN117562962B (zh) * 2024-01-15 2024-03-12 四川育强本草生物技术有限公司 美洲大蠊或其提取物的用途及一种治疗猫口炎的中兽药组合物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808629A (en) * 1985-05-28 1989-02-28 Yaguang Liu Safe antileukemia drug, SAL
JPS6299318A (ja) * 1985-10-25 1987-05-08 Nonogawa Shoji:Kk 養毛剤
US4886666A (en) * 1987-01-27 1989-12-12 Yaguang Liu Pharmaceutical composition for inhibiting viruses and increasing immune function (PII)
US4985248A (en) * 1987-06-18 1991-01-15 Yaguang Liu Pharmaceutical composition containing a safe extracts of fruits and vegetables for the treating and preventing of diabetes
JP2974370B2 (ja) * 1990-05-11 1999-11-10 社団法人北里研究所 シアリダーゼ阻害剤
JPH0426650A (ja) * 1990-05-17 1992-01-29 Kuraray Co Ltd オレアノール酸の製造法
US5178865A (en) * 1990-06-19 1993-01-12 Cedars-Sinai Medical Center Chinese herbal extracts in the treatment of hiv related disease in vitro
JPH0645550B2 (ja) * 1990-06-27 1994-06-15 新也 大久保 抗癌剤
US5366725A (en) * 1990-06-27 1994-11-22 Shinya Okubo Method for the treatment of cancer
CN1077379A (zh) * 1992-04-16 1993-10-20 张笑平 乙肝表面抗原转阴冲剂及其制备方法
US5411733A (en) * 1992-04-27 1995-05-02 Hozumi; Toyoharu Antiviral agent containing crude drug
CN1049338C (zh) * 1993-03-20 2000-02-16 赵三立 治疗乙型肝炎的药液
CN1045387C (zh) * 1993-05-20 1999-10-06 李永光 三草乙肝散
JP3183754B2 (ja) * 1993-07-20 2001-07-09 ポーラ化成工業株式会社 動脈硬化抑制剤及びこれを含有する組成物
CN1052413C (zh) * 1994-01-17 2000-05-17 江洋 一种治疗肝炎的药物茵黄冲剂及其制备方法
CN1105683A (zh) * 1994-01-18 1995-07-26 龚枫砰 黄色保健(着色剂)染料制备方法
CN1124153A (zh) * 1994-12-06 1996-06-12 蒋正文 复元益肝药物及其制备方法
CN1109710A (zh) * 1994-12-27 1995-10-11 李灵山 三尖杉鹿寿保健茶及其制备方法
US5837257A (en) * 1996-07-09 1998-11-17 Sage R&D Use of plant extracts for treatment of HIV, HCV and HBV infections

Also Published As

Publication number Publication date
AU742854B2 (en) 2002-01-17
EP0914139A2 (de) 1999-05-12
CA2271622C (en) 2002-12-17
NZ333707A (en) 2000-09-29
CA2271622A1 (en) 1998-01-15
BR9710355A (pt) 2000-01-11
WO1998001144A1 (en) 1998-01-15
AU3664297A (en) 1998-02-02
EP0914139B1 (de) 2008-02-27
KR20000023648A (ko) 2000-04-25
KR100511514B1 (ko) 2005-08-31
US5989556A (en) 1999-11-23
DE69738535D1 (de) 2008-04-10
US5837257A (en) 1998-11-17
ES2303342T3 (es) 2008-08-01
JP2001516337A (ja) 2001-09-25
DE69738535T2 (de) 2009-02-19
US6214350B1 (en) 2001-04-10

Similar Documents

Publication Publication Date Title
DE69738535D1 (de) Antivirale mittel aus pflanzenextrakten und deren verwendung zur behandlung viraler infektionen
WO1998001144A2 (en) Antiviral agents from plant extracts and use for treatment of viral infections
ATE264914T1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
WO2003051306A3 (en) N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
DE60229677D1 (de) Langwirkende Fusionspeptidinhibitoren gegen HIV-Infektion
ATE219366T1 (de) Verwendung von 5-fluoro-2'-deoxy-3'-thiacytidin zur behandlung von hepatitis b
DK0980203T3 (da) Antimikrobiel forebyggelse og behandling af humant immundeficiensvirus og andre infektiöse sygdomme
WO2001010456A3 (en) Peptides that block viral infectivity and methods of use thereof
ES2187530T3 (es) Peptidos para reducir respuestas de linfocito t ctitotoxicos al virus de la hepatitis b.
GEP20084377B (en) Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections
ATE152717T1 (de) Gegen viren wirksame naphtochinon-verbindungen, zusammensetzungen und deren verwendungen
ES2105923A1 (es) Composiciones para el tratamiento de una infeccion y una enfermedad causadas por el virus de la hepatitis b (hbv).
MY157594A (en) Compositions of matter useful in the treatment of viral infections derived from plant extracts
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
RU93058325A (ru) Применение производных 1,3-оксатиолана для получения лекарственных препаратов для лечения или профилактики вирусной инфекции гепатита в, применение производных 1,3 - оксатиолана для лечения инфекций гепатита в, способ лечения гепатита в
CA2401295A1 (en) Process for preparing an anti viral medicinal product from plant extracts
BG101175A (bg) Тройна анти-нiv комбинация
UA41338C2 (uk) Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл)
KR950702838A (ko) 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4)
EP0963441A4 (de) Inaktivierung von hiv ko-rezeptoren zur therapie der hiv-infektion
WO2001030325A3 (en) Use of a bis-peroxovanadium compound for the treatment of immunosuppressed patients
BR0207931A (pt) Anticorpos naturais ativos contra vìrus hiv
ATE189604T1 (de) Extrakte von piliostigma thonningii, deren verwendung und diese enthaltende zubereitungen
BR0008269A (pt) Uso de uma preparação de m. vaccae, e, método para tratamento de infecção viral crÈnica, excluindo infecção por hiv
WO2002009677A3 (en) Method to treat infectious diseases and/or to enhance antimicrobial efficacy of drugs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties